Literature DB >> 24532906

Evolution of the role of army transfusion services in the management of trauma patients and battle casualties with massive hemorrhage.

R S Sarkar1, J Philip2, S Kumar3, Pramod Yadav4.   

Abstract

Providing blood at the times of national emergencies and war-like scenarios is a challenge to the blood transfusion services. The dictum should be adequate bleeding, minimum storage time, quick transportation and maximum utilization of blood as soon as possible. For the successful implementation of its role, forward transfusion services should be fully mobile with integral transportation and communication systems. Supplementation of blood supplies has to be prompt, & for this adequate air transport facilities will have to be established. A rational approach to using blood products in patients with bleeding, requires an understanding of the principles of managing hemorrhagic shock. The main priorities are controlling hemorrhage and restoring adequate oxygen delivery to the tissues. Surgical control and treatment of coagulopathy are required to stop hemorrhage in these patients. Resuscitation with fluids and red cells are necessary to improve perfusion and oxygen delivery to tissues. Once patients are resuscitated and further bleeding is stopped, use of conservative transfusion triggers is recommended to avoid excessive transfusion and adverse outcomes. A host of new technologies are being developed that have the potential of reducing blood loss. These will help in reducing the transfusion requirements in trauma patients with massive hemorrhage.

Entities:  

Keywords:  Coagulopathy; Hemorrhage; Hemorrhagic shock; Volume resuscitation

Year:  2012        PMID: 24532906      PMCID: PMC3862615          DOI: 10.1016/j.mjafi.2012.07.002

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  22 in total

1.  Blood use in war and disaster: lessons from the past century.

Authors:  J R Hess; M J G Thomas
Journal:  Transfusion       Date:  2003-11       Impact factor: 3.157

2.  Blood antibodies and uncrossmatched type O blood.

Authors:  D Unkle; R Smejkal; R Snyder; M Lessig; S E Ross
Journal:  Heart Lung       Date:  1991-05       Impact factor: 2.210

3.  Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.

Authors: 
Journal:  Anesthesiology       Date:  1996-03       Impact factor: 7.892

4.  Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists.

Authors: 
Journal:  JAMA       Date:  1994-03-09       Impact factor: 56.272

Review 5.  Antifibrinolytic drugs for acute traumatic injury.

Authors:  T Coats; I Roberts; H Shakur
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

Review 6.  Coagulation defects in trauma patients: etiology, recognition, and therapy.

Authors:  Thomas G DeLoughery
Journal:  Crit Care Clin       Date:  2004-01       Impact factor: 3.598

Review 7.  Treating coagulopathy in trauma patients.

Authors:  Ray Armand; John R Hess
Journal:  Transfus Med Rev       Date:  2003-07

8.  Resuscitation of trauma patients with type-specific uncrossmatched blood.

Authors:  A S Gervin; R P Fischer
Journal:  J Trauma       Date:  1984-04

Review 9.  Cell salvage for minimising perioperative allogeneic blood transfusion.

Authors:  P A Carless; D A Henry; A J Moxey; D L O'Connell; D A Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 10.  Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.

Authors:  P A Carless; D A Henry; D M Anthony
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.